НовостиBenzingaPiper Sandler Maintains Overweight on BridgeBio Oncology, Lowers Price Target to $15 Piper Sandler Maintains Overweight on BridgeBio Oncology, Lowers Price Target to $15 Benzinga 2026.11.11 14:22 (GMT+0) Открыть на Benzinga Другие новости